Mesoblast Limited
MESO
$16.11
$0.090.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 344.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 344.93% | |||
| Cost of Revenue | 0.00% | 808.83% | |||
| Gross Profit | 0.00% | -434.05% | |||
| SG&A Expenses | 0.00% | 28.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.00% | 718.60% | |||
| Total Operating Expenses | 0.00% | 144.17% | |||
| Operating Income | 0.00% | -112.46% | |||
| Income Before Tax | 0.00% | -13.34% | |||
| Income Tax Expenses | 0.00% | -44.34% | |||
| Earnings from Continuing Operations | 0.00% | -13.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -13.09% | |||
| EBIT | 0.00% | -112.46% | |||
| EBITDA | 0.00% | -107.69% | |||
| EPS Basic | 0.00% | -1.43% | |||
| Normalized Basic EPS | 0.00% | 10.08% | |||
| EPS Diluted | 0.00% | -1.43% | |||
| Normalized Diluted EPS | 0.00% | 10.08% | |||
| Average Basic Shares Outstanding | 0.00% | 11.47% | |||
| Average Diluted Shares Outstanding | 0.00% | 11.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||